Sep 2026
Therapeutic evaluation of a first-generation L. amazonensis antigen vaccine with TLR-3 ligand adjuvant.
Leishmaniasis is an expanding parasitic zoonosis in South America and is considered one of the neglected diseases by the WHO because it primarily affects low-income populations with limited access to healthcare services. Currently, there is no vaccine available for the prevention of human leishmaniasis, and existing tr...
Victoria J. Arrieta, M. J. Germanó, M. V. Sanchez et al.
· Acta Tropica · 0 citations